Red blood cell aggregation, aggregate strength and oxygen transport potential of blood are abnormal in both homozygous sickle cell anemia and sickle-hemoglobin C disease

1 EA 3596, Laboratoire ACTES, Département de Physiologie, Université des Antilles et de la Guyane, Campus de Fouillole, Pointe-à-Pitre, Guadeloupe 2 UMR S 763 Inserm/Université des Antilles et de la Guyane, CHU Pointe-à-Pitre, Guadeloupe 3 Department of Physiology and Biophysics, University of South...

Full description

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 94; no. 8; pp. 1060 - 1065
Main Authors Tripette, Julien, Alexy, Tamas, Hardy-Dessources, Marie-Dominique, Mougenel, Daniele, Beltan, Eric, Chalabi, Tawfik, Chout, Roger, Etienne-Julan, Maryse, Hue, Olivier, Meiselman, Herbert J, Connes, Philippe
Format Journal Article
LanguageEnglish
Published Pavia Ferrata Storti Foundation 01.08.2009
Subjects
Online AccessGet full text
ISSN0390-6078
1592-8721
1592-8721
DOI10.3324/haematol.2008.005371

Cover

Abstract 1 EA 3596, Laboratoire ACTES, Département de Physiologie, Université des Antilles et de la Guyane, Campus de Fouillole, Pointe-à-Pitre, Guadeloupe 2 UMR S 763 Inserm/Université des Antilles et de la Guyane, CHU Pointe-à-Pitre, Guadeloupe 3 Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA 4 Caribbean Sickle Cell Center, Pointe-à-Pitre, Guadeloupe 5 Department of Hematology/Immunology, Academic Hospital of Pointe-à-Pitre, Guadeloupe Correspondence: Philippe Connes, PhD, Laboratoire ACTES (EA 3596), Département de Physiologie, Université des Antilles et de la Guyane, Campus de Fouillole, 97159 Pointe-à-Pitre, Guadeloupe (French West Indies). E-mail: pconnes{at}yahoo.fr Background: Recent evidence suggests that red blood cell aggregation and the ratio of hematocrit to blood viscosity (HVR), an index of the oxygen transport potential of blood, might considerably modulate blood flow dynamics in the microcirculation. It thus seems likely that these factors could play a role in sickle cell disease. Design and Methods: We compared red blood cell aggregation characteristics, blood viscosity and HVR at different shear rates between sickle cell anemia and sickle cell hemoglobin C disease (SCC) patients, sickle cell trait carriers (AS) and control individuals (AA). Results: Blood viscosity determined at high shear rate was lower in sickle cell anemia (n=21) than in AA (n=52), AS (n=33) or SCC (n=21), and was markedly increased in both SCC and AS. Despite differences in blood viscosity, both sickle cell anemia and SCC had similar low HVR values compared to both AA and AS. Sickle cell anemia (n=21) and SCC (n=19) subjects had a lower red blood cell aggregation index and longer time for red blood cell aggregates formation than AA (n=16) and AS (n=15), and a 2 to 3 fold greater shear rate required to disperse red blood cell aggregates. Conclusions: The low HVR levels found in sickle cell anemia and SCC indicates a comparable low oxygen transport potential of blood in both genotypes. Red blood cell aggregation properties are likely to be involved in the pathophysiology of sickle cell disease: the increased shear forces needed to disperse red blood cell aggregates may disturb blood flow, especially at the microcirculatory level, since red blood cell are only able to pass through narrow capillaries as single cells rather than as aggregates. Key words: sickle cell disease, red blood cell aggregation, viscosity, red blood cell deformability.
AbstractList Recent evidence suggests that red cell aggregation and the ratio of hematocrit to blood viscosity, an index of the oxygen transport potential of blood, might considerably modulate blood flow dynamics in the microcirculation. The findings of this study indicate that patients with sickle cell disease and those with sickle cell hemoglobin C disease have low ratios of hematocrit to blood viscosity as compared to normal controls. This may play a role in tissue hypoxia and clinical status of these patients.
1 EA 3596, Laboratoire ACTES, Département de Physiologie, Université des Antilles et de la Guyane, Campus de Fouillole, Pointe-à-Pitre, Guadeloupe 2 UMR S 763 Inserm/Université des Antilles et de la Guyane, CHU Pointe-à-Pitre, Guadeloupe 3 Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA 4 Caribbean Sickle Cell Center, Pointe-à-Pitre, Guadeloupe 5 Department of Hematology/Immunology, Academic Hospital of Pointe-à-Pitre, Guadeloupe Correspondence: Philippe Connes, PhD, Laboratoire ACTES (EA 3596), Département de Physiologie, Université des Antilles et de la Guyane, Campus de Fouillole, 97159 Pointe-à-Pitre, Guadeloupe (French West Indies). E-mail: pconnes{at}yahoo.fr Background: Recent evidence suggests that red blood cell aggregation and the ratio of hematocrit to blood viscosity (HVR), an index of the oxygen transport potential of blood, might considerably modulate blood flow dynamics in the microcirculation. It thus seems likely that these factors could play a role in sickle cell disease. Design and Methods: We compared red blood cell aggregation characteristics, blood viscosity and HVR at different shear rates between sickle cell anemia and sickle cell hemoglobin C disease (SCC) patients, sickle cell trait carriers (AS) and control individuals (AA). Results: Blood viscosity determined at high shear rate was lower in sickle cell anemia (n=21) than in AA (n=52), AS (n=33) or SCC (n=21), and was markedly increased in both SCC and AS. Despite differences in blood viscosity, both sickle cell anemia and SCC had similar low HVR values compared to both AA and AS. Sickle cell anemia (n=21) and SCC (n=19) subjects had a lower red blood cell aggregation index and longer time for red blood cell aggregates formation than AA (n=16) and AS (n=15), and a 2 to 3 fold greater shear rate required to disperse red blood cell aggregates. Conclusions: The low HVR levels found in sickle cell anemia and SCC indicates a comparable low oxygen transport potential of blood in both genotypes. Red blood cell aggregation properties are likely to be involved in the pathophysiology of sickle cell disease: the increased shear forces needed to disperse red blood cell aggregates may disturb blood flow, especially at the microcirculatory level, since red blood cell are only able to pass through narrow capillaries as single cells rather than as aggregates. Key words: sickle cell disease, red blood cell aggregation, viscosity, red blood cell deformability.
Background Recent evidence suggests that red blood cell aggregation and the ratio of hematocrit to blood viscosity (HVR), an index of the oxygen transport potential of blood, might considerably modulate blood flow dynamics in the microcirculation. It thus seems likely that these factors could play a role in sickle cell disease.Design and Methods We compared red blood cell aggregation characteristics, blood viscosity and HVR at different shear rates between sickle cell anemia and sickle cell hemoglobin C disease (SCC) patients, sickle cell trait carriers (AS) and control individuals (AA).Results Blood viscosity determined at high shear rate was lower in sickle cell anemia (n=21) than in AA (n=52), AS (n=33) or SCC (n=21), and was markedly increased in both SCC and AS. Despite differences in blood viscosity, both sickle cell anemia and SCC had similar low HVR values compared to both AA and AS. Sickle cell anemia (n=21) and SCC (n=19) subjects had a lower red blood cell aggregation index and longer time for red blood cell aggregates formation than AA (n=16) and AS (n=15), and a 2 to 3 fold greater shear rate required to disperse red blood cell aggregates.Conclusions The low HVR levels found in sickle cell anemia and SCC indicates a comparable low oxygen transport potential of blood in both genotypes. Red blood cell aggregation properties are likely to be involved in the pathophysiology of sickle cell disease: the increased shear forces needed to disperse red blood cell aggregates may disturb blood flow, especially at the microcirculatory level, since red blood cell are only able to pass through narrow capillaries as single cells rather than as aggregates.
Recent evidence suggests that red blood cell aggregation and the ratio of hematocrit to blood viscosity (HVR), an index of the oxygen transport potential of blood, might considerably modulate blood flow dynamics in the microcirculation. It thus seems likely that these factors could play a role in sickle cell disease.BACKGROUNDRecent evidence suggests that red blood cell aggregation and the ratio of hematocrit to blood viscosity (HVR), an index of the oxygen transport potential of blood, might considerably modulate blood flow dynamics in the microcirculation. It thus seems likely that these factors could play a role in sickle cell disease.We compared red blood cell aggregation characteristics, blood viscosity and HVR at different shear rates between sickle cell anemia and sickle cell hemoglobin C disease (SCC) patients, sickle cell trait carriers (AS) and control individuals (AA).DESIGN AND METHODSWe compared red blood cell aggregation characteristics, blood viscosity and HVR at different shear rates between sickle cell anemia and sickle cell hemoglobin C disease (SCC) patients, sickle cell trait carriers (AS) and control individuals (AA).Blood viscosity determined at high shear rate was lower in sickle cell anemia (n=21) than in AA (n=52), AS (n=33) or SCC (n=21), and was markedly increased in both SCC and AS. Despite differences in blood viscosity, both sickle cell anemia and SCC had similar low HVR values compared to both AA and AS. Sickle cell anemia (n=21) and SCC (n=19) subjects had a lower red blood cell aggregation index and longer time for red blood cell aggregates formation than AA (n=16) and AS (n=15), and a 2 to 3 fold greater shear rate required to disperse red blood cell aggregates.RESULTSBlood viscosity determined at high shear rate was lower in sickle cell anemia (n=21) than in AA (n=52), AS (n=33) or SCC (n=21), and was markedly increased in both SCC and AS. Despite differences in blood viscosity, both sickle cell anemia and SCC had similar low HVR values compared to both AA and AS. Sickle cell anemia (n=21) and SCC (n=19) subjects had a lower red blood cell aggregation index and longer time for red blood cell aggregates formation than AA (n=16) and AS (n=15), and a 2 to 3 fold greater shear rate required to disperse red blood cell aggregates.The low HVR levels found in sickle cell anemia and SCC indicates a comparable low oxygen transport potential of blood in both genotypes. Red blood cell aggregation properties are likely to be involved in the pathophysiology of sickle cell disease: the increased shear forces needed to disperse red blood cell aggregates may disturb blood flow, especially at the microcirculatory level, since red blood cell are only able to pass through narrow capillaries as single cells rather than as aggregates.CONCLUSIONSThe low HVR levels found in sickle cell anemia and SCC indicates a comparable low oxygen transport potential of blood in both genotypes. Red blood cell aggregation properties are likely to be involved in the pathophysiology of sickle cell disease: the increased shear forces needed to disperse red blood cell aggregates may disturb blood flow, especially at the microcirculatory level, since red blood cell are only able to pass through narrow capillaries as single cells rather than as aggregates.
Recent evidence suggests that red blood cell aggregation and the ratio of hematocrit to blood viscosity (HVR), an index of the oxygen transport potential of blood, might considerably modulate blood flow dynamics in the microcirculation. It thus seems likely that these factors could play a role in sickle cell disease. We compared red blood cell aggregation characteristics, blood viscosity and HVR at different shear rates between sickle cell anemia and sickle cell hemoglobin C disease (SCC) patients, sickle cell trait carriers (AS) and control individuals (AA). Blood viscosity determined at high shear rate was lower in sickle cell anemia (n=21) than in AA (n=52), AS (n=33) or SCC (n=21), and was markedly increased in both SCC and AS. Despite differences in blood viscosity, both sickle cell anemia and SCC had similar low HVR values compared to both AA and AS. Sickle cell anemia (n=21) and SCC (n=19) subjects had a lower red blood cell aggregation index and longer time for red blood cell aggregates formation than AA (n=16) and AS (n=15), and a 2 to 3 fold greater shear rate required to disperse red blood cell aggregates. The low HVR levels found in sickle cell anemia and SCC indicates a comparable low oxygen transport potential of blood in both genotypes. Red blood cell aggregation properties are likely to be involved in the pathophysiology of sickle cell disease: the increased shear forces needed to disperse red blood cell aggregates may disturb blood flow, especially at the microcirculatory level, since red blood cell are only able to pass through narrow capillaries as single cells rather than as aggregates.
Author Mougenel, Daniele
Hue, Olivier
Meiselman, Herbert J
Hardy-Dessources, Marie-Dominique
Etienne-Julan, Maryse
Chout, Roger
Tripette, Julien
Connes, Philippe
Beltan, Eric
Alexy, Tamas
Chalabi, Tawfik
AuthorAffiliation 3 Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA
5 Department of Hematology/Immunology, Academic Hospital of Pointe-à-Pitre, Guadeloupe
1 EA 3596, Laboratoire ACTES, Département de Physiologie, Université des Antilles et de la Guyane, Campus de Fouillole, Pointe-à-Pitre, Guadeloupe
2 UMR S 763 Inserm/Université des Antilles et de la Guyane, CHU Pointe-à-Pitre, Guadeloupe
4 Caribbean Sickle Cell Center, Pointe-à-Pitre, Guadeloupe
AuthorAffiliation_xml – name: 5 Department of Hematology/Immunology, Academic Hospital of Pointe-à-Pitre, Guadeloupe
– name: 4 Caribbean Sickle Cell Center, Pointe-à-Pitre, Guadeloupe
– name: 2 UMR S 763 Inserm/Université des Antilles et de la Guyane, CHU Pointe-à-Pitre, Guadeloupe
– name: 1 EA 3596, Laboratoire ACTES, Département de Physiologie, Université des Antilles et de la Guyane, Campus de Fouillole, Pointe-à-Pitre, Guadeloupe
– name: 3 Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA
Author_xml – sequence: 1
  fullname: Tripette, Julien
– sequence: 2
  fullname: Alexy, Tamas
– sequence: 3
  fullname: Hardy-Dessources, Marie-Dominique
– sequence: 4
  fullname: Mougenel, Daniele
– sequence: 5
  fullname: Beltan, Eric
– sequence: 6
  fullname: Chalabi, Tawfik
– sequence: 7
  fullname: Chout, Roger
– sequence: 8
  fullname: Etienne-Julan, Maryse
– sequence: 9
  fullname: Hue, Olivier
– sequence: 10
  fullname: Meiselman, Herbert J
– sequence: 11
  fullname: Connes, Philippe
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21778263$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19644138$$D View this record in MEDLINE/PubMed
https://hal.science/hal-04596392$$DView record in HAL
BookMark eNqNUk1v1DAUjFARbRf-AUK-AEJii78SJxyQqgpopUpICM6WY78kLk68tbNdln_Ev8TbhIX2AifL4zfz_GbecXYw-AGy7CnBJ4xR_qZT0KvRuxOKcXmCcc4EeZAdkbyiy1JQcpAdYVbhZYFFeZgdx3iFMcVVJR5lh6QqOCesPMp-fgaDaue9QRqcQ6ptA7RqtH54vb8AimOAoR07pAaD_PdtCwMagxriyocRrfwIw2iVQ76ZxVQApOrBhz6hdkC1T-TO9_7HtvXriKLV3xzMPQforbqVnuBlB71vna8T8QwZG0FFeJw9bJSL8GQ-F9nXD--_nJ0vLz99vDg7vVzqvCjHZcFFKUBjVlNOwRhdixzXgDGhgHXCK14aUpg8zwGTuqlJIlSYaihrpuuCLbKLSdd4dSVXwfYqbKVXVt4CPrRShdFqB5IXjAleNcKA4hxI1UADrEqSBqgwKmnlk9Z6WKntRjm3FyRY7mKUv2OUuxjlFGPivZt4q3Xdg9HJ3aDcnc_cfRlsJ1t_I6kgaZYyCbyaBLp7tPPTS7nDMM-rglX0Ztfs5dws-Os1xFH2Nu6CSbmkqKRgLE9T8p01z_7-1p9Z5nVKBc_nAhW1ck3aEG3jvo4SIUqaTFtkfKrTwccYoPlfW97eo2k73u5qMsG6f5FfzJbYttvYADKm3XRpFCo3m03FZZkECsx-AUKSElM
CitedBy_id crossref_primary_10_1111_bjh_14852
crossref_primary_10_1136_bjsports_2015_095317
crossref_primary_10_1111_bjh_13363
crossref_primary_10_3233_CH_189119
crossref_primary_10_1016_j_lpm_2023_104210
crossref_primary_10_1038_s41467_023_40522_4
crossref_primary_10_1111_j_1537_2995_2012_03779_x
crossref_primary_10_4236_ojpm_2015_54019
crossref_primary_10_1590_1807_3107BOR_2016_vol30_0060
crossref_primary_10_3389_fphar_2021_636457
crossref_primary_10_1038_s41598_018_34600_7
crossref_primary_10_3389_fneur_2019_00871
crossref_primary_10_3390_cells10040811
crossref_primary_10_1182_bloodadvances_2019000387
crossref_primary_10_1111_bjh_12300
crossref_primary_10_3390_ijms25073732
crossref_primary_10_1111_bjh_12786
crossref_primary_10_3233_CH_162042
crossref_primary_10_3233_CH_201037
crossref_primary_10_3389_fgene_2020_00848
crossref_primary_10_3390_antiox10101608
crossref_primary_10_1016_j_blre_2015_08_005
crossref_primary_10_1016_j_pacs_2024_100599
crossref_primary_10_3389_fphys_2022_916197
crossref_primary_10_2174_1874070701812010086
crossref_primary_10_1016_j_jbiomech_2025_112603
crossref_primary_10_5301_ejo_5000598
crossref_primary_10_1371_journal_pone_0286543
crossref_primary_10_1002_ajh_25933
crossref_primary_10_1152_ajpheart_00298_2010
crossref_primary_10_1111_bjh_13185
crossref_primary_10_1371_journal_pone_0066004
crossref_primary_10_3233_CH_170280
crossref_primary_10_3390_jcm12206620
crossref_primary_10_1093_ajcp_aqab196
crossref_primary_10_1371_journal_pone_0079086
crossref_primary_10_1016_j_bcmd_2016_04_012
crossref_primary_10_1016_j_pdpdt_2021_102276
crossref_primary_10_1007_s11277_020_07633_3
crossref_primary_10_1182_blood_2014_10_605964
crossref_primary_10_1016_j_crvi_2012_09_003
crossref_primary_10_1371_journal_pone_0114412
crossref_primary_10_3389_fcvm_2018_00138
crossref_primary_10_1016_j_bcmd_2016_10_020
crossref_primary_10_1182_blood_2024024608
crossref_primary_10_1007_s10439_017_1863_z
crossref_primary_10_1111_bjh_19832
crossref_primary_10_3233_CH_189201
crossref_primary_10_3233_CH_190671
crossref_primary_10_3389_fimmu_2020_00454
crossref_primary_10_1182_blood_2022018229
crossref_primary_10_3390_ijms24043621
crossref_primary_10_3233_CH_170310
crossref_primary_10_1371_journal_pone_0095563
crossref_primary_10_1371_journal_pone_0068929
crossref_primary_10_1007_s00421_021_04821_2
crossref_primary_10_1371_journal_pone_0052471
crossref_primary_10_1371_journal_pone_0077830
crossref_primary_10_1002_ajh_26440
crossref_primary_10_1016_j_febslet_2012_12_015
crossref_primary_10_3390_jcm9010133
crossref_primary_10_3233_CH_141891
crossref_primary_10_1093_bib_bbad232
crossref_primary_10_1136_bjsports_2012_091038
crossref_primary_10_3233_CH_160218
crossref_primary_10_3390_cells11030585
crossref_primary_10_1016_j_bpj_2018_12_008
crossref_primary_10_3390_jcm8122155
crossref_primary_10_1039_C3SM52860J
crossref_primary_10_1016_j_smrv_2015_01_007
crossref_primary_10_1021_acsabm_4c00516
crossref_primary_10_3109_07420528_2013_804083
crossref_primary_10_1111_bjh_12912
crossref_primary_10_3389_fcvm_2022_883812
crossref_primary_10_3389_fphys_2023_1151268
crossref_primary_10_3389_fphys_2019_01329
crossref_primary_10_1089_ars_2011_4282
crossref_primary_10_3233_CH_238122
crossref_primary_10_3389_fphys_2019_01443
crossref_primary_10_1182_bloodadvances_2024014201
crossref_primary_10_1002_ajh_25345
crossref_primary_10_1002_pbc_29363
crossref_primary_10_1016_j_cis_2023_102870
crossref_primary_10_3390_fluids5030125
crossref_primary_10_1111_j_1537_2995_2012_03822_x
crossref_primary_10_1089_bio_2018_0023
crossref_primary_10_1002_ajh_23312
crossref_primary_10_3109_03630269_2014_888353
crossref_primary_10_1371_journal_pone_0158182
crossref_primary_10_1111_ejh_13607
crossref_primary_10_1002_ajh_23318
crossref_primary_10_1111_micc_12317
crossref_primary_10_1016_j_bcmd_2017_02_001
crossref_primary_10_3233_CH_189005
crossref_primary_10_3233_CH_189006
crossref_primary_10_1098_rsfs_2015_0065
crossref_primary_10_1007_s00540_022_03109_9
crossref_primary_10_1016_j_lpm_2023_104202
crossref_primary_10_3174_ajnr_A4793
crossref_primary_10_1111_j_1537_2995_2012_03961_x
crossref_primary_10_1007_s11239_024_03040_8
crossref_primary_10_3390_biology13110948
crossref_primary_10_3233_CH_151979
crossref_primary_10_3390_ma13184184
crossref_primary_10_1016_j_bpj_2023_03_030
crossref_primary_10_1111_j_1365_2141_2011_08728_x
crossref_primary_10_3233_CH_168042
crossref_primary_10_1007_s10483_019_2473_6
crossref_primary_10_1039_C4IB00025K
crossref_primary_10_1371_journal_pone_0229105
crossref_primary_10_3233_CH_151972
ContentType Journal Article
Copyright 2009 INIST-CNRS
Distributed under a Creative Commons Attribution 4.0 International License
Copyright© Ferrata Storti Foundation
Copyright_xml – notice: 2009 INIST-CNRS
– notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: Copyright© Ferrata Storti Foundation
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
VOOES
5PM
ADTOC
UNPAY
DOA
DOI 10.3324/haematol.2008.005371
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
Open Access资源_DOAJ
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1592-8721
EndPage 1065
ExternalDocumentID oai_doaj_org_article_4633749f7dea44e19fefe39b14de27da
10.3324/haematol.2008.005371
PMC2719028
oai_HAL_hal_04596392v1
19644138
21778263
10_3324_haematol_2008_005371
www94_8_1060
Genre Journal Article
GroupedDBID -
29I
2WC
53G
5GY
5RE
5VS
ABFLS
ADACO
ADBBV
AENEX
AGCAB
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
C1A
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GROUPED_DOAJ
H13
HYE
KQ8
M~E
O0-
OK1
P2P
RHF
RHI
RNS
RPM
SJN
TFS
WOQ
WOW
ZA5
---
AAFWJ
AAYXX
AFPKN
AOIJS
BTFSW
CITATION
OVT
TR2
W8F
IQODW
UDS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
VOOES
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c568t-64787ec03b242eddcb750be0012e0cc03948d16d555e01bfb1478902ce8b3cb63
IEDL.DBID DOA
ISSN 0390-6078
1592-8721
IngestDate Wed Aug 27 01:31:21 EDT 2025
Wed Oct 01 16:07:15 EDT 2025
Thu Aug 21 18:42:24 EDT 2025
Fri Sep 12 12:42:39 EDT 2025
Fri Jul 11 04:42:30 EDT 2025
Mon Jul 21 05:54:36 EDT 2025
Mon Jul 21 09:14:40 EDT 2025
Tue Jul 01 04:21:39 EDT 2025
Thu Apr 24 23:10:17 EDT 2025
Tue Jan 05 20:16:40 EST 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Viscosity
Hemoglobinopathy
Oxygen
Sickle cell anemia
Deformability
Hemoglobin C
Hematology
Red blood cell
red blood cell aggregation
Hemopathy
Homozygosity
Blood
Genetic disease
sickle cell disease
Aggregation
Blood cell
Hemolytic anemia
Aggregate
Transport
red blood cell deformability
Strength
Red blood cell deformability
Sickle cell disease
Red blood cell aggregation
Language English
License CC BY 4.0
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c568t-64787ec03b242eddcb750be0012e0cc03948d16d555e01bfb1478902ce8b3cb63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5669-5337
0000-0002-9232-0268
0000-0002-2155-0816
OpenAccessLink https://doaj.org/article/4633749f7dea44e19fefe39b14de27da
PMID 19644138
PQID 733574946
PQPubID 23479
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_4633749f7dea44e19fefe39b14de27da
unpaywall_primary_10_3324_haematol_2008_005371
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2719028
hal_primary_oai_HAL_hal_04596392v1
proquest_miscellaneous_733574946
pubmed_primary_19644138
pascalfrancis_primary_21778263
crossref_primary_10_3324_haematol_2008_005371
crossref_citationtrail_10_3324_haematol_2008_005371
highwire_smallpub2_www94_8_1060
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-08-01
PublicationDateYYYYMMDD 2009-08-01
PublicationDate_xml – month: 08
  year: 2009
  text: 2009-08-01
  day: 01
PublicationDecade 2000
PublicationPlace Pavia
PublicationPlace_xml – name: Pavia
– name: Italy
PublicationTitle Haematologica (Roma)
PublicationTitleAlternate Haematologica
PublicationYear 2009
Publisher Ferrata Storti Foundation
Publisher_xml – name: Ferrata Storti Foundation
References 18499764 - Br J Sports Med. 2010 Mar;44(4):232-7
6294138 - J Clin Invest. 1982 Dec;70(6):1253-9
2947642 - Blood. 1987 Jan;69(1):124-30
7174796 - J Clin Invest. 1982 Dec;70(6):1315-9
2348499 - J Trop Med Hyg. 1990 Jun;93(3):210-4
11299197 - Am J Physiol Heart Circ Physiol. 2001 May;280(5):H1982-8
9436619 - Free Radic Biol Med. 1998 Jan 1;24(1):102-10
15474138 - Lancet. 2004 Oct 9-15;364(9442):1343-60
18937523 - Sports Med. 2008;38(11):931-46
6690472 - J Clin Invest. 1984 Jan;73(1):116-23
3209393 - Hemoglobin. 1988;12(5-6):509-17
6712910 - Br J Ophthalmol. 1984 May;68(5):325-8
14194270 - Blood. 1964 Jul;24:25-48
17993789 - Clin J Sport Med. 2007 Nov;17(6):465-70
2424491 - Br J Ophthalmol. 1986 Jul;70(7):522-5
3401593 - Blood. 1988 Aug;72(2):539-45
16899945 - Clin Hemorheol Microcirc. 2006;35(1-2):291-5
3590284 - Transfusion. 1987 May-Jun;27(3):228-33
16269018 - Eur J Clin Invest. 2005 Nov;35(11):687-90
11790865 - Clin Hemorheol Microcirc. 2001;25(1):1-11
19065010 - Biorheology. 2008;45(6):629-38
61453 - Lancet. 1976 Oct 9;2(7989):784-6
16734807 - Transfusion. 2006 Jun;46(6):912-8
5443167 - J Clin Invest. 1970 Apr;49(4):623-34
16015123 - Med Sci Sports Exerc. 2005 Jul;37(7):1086-92
18608991 - Microcirculation. 2008 Oct;15(7):585-90
10607725 - Blood. 2000 Jan 1;95(1):360-2
References_xml – reference: 16269018 - Eur J Clin Invest. 2005 Nov;35(11):687-90
– reference: 16734807 - Transfusion. 2006 Jun;46(6):912-8
– reference: 5443167 - J Clin Invest. 1970 Apr;49(4):623-34
– reference: 2348499 - J Trop Med Hyg. 1990 Jun;93(3):210-4
– reference: 10607725 - Blood. 2000 Jan 1;95(1):360-2
– reference: 18608991 - Microcirculation. 2008 Oct;15(7):585-90
– reference: 6712910 - Br J Ophthalmol. 1984 May;68(5):325-8
– reference: 11299197 - Am J Physiol Heart Circ Physiol. 2001 May;280(5):H1982-8
– reference: 14194270 - Blood. 1964 Jul;24:25-48
– reference: 61453 - Lancet. 1976 Oct 9;2(7989):784-6
– reference: 2424491 - Br J Ophthalmol. 1986 Jul;70(7):522-5
– reference: 11790865 - Clin Hemorheol Microcirc. 2001;25(1):1-11
– reference: 3209393 - Hemoglobin. 1988;12(5-6):509-17
– reference: 17993789 - Clin J Sport Med. 2007 Nov;17(6):465-70
– reference: 19065010 - Biorheology. 2008;45(6):629-38
– reference: 3590284 - Transfusion. 1987 May-Jun;27(3):228-33
– reference: 18499764 - Br J Sports Med. 2010 Mar;44(4):232-7
– reference: 18937523 - Sports Med. 2008;38(11):931-46
– reference: 6294138 - J Clin Invest. 1982 Dec;70(6):1253-9
– reference: 16015123 - Med Sci Sports Exerc. 2005 Jul;37(7):1086-92
– reference: 15474138 - Lancet. 2004 Oct 9-15;364(9442):1343-60
– reference: 7174796 - J Clin Invest. 1982 Dec;70(6):1315-9
– reference: 6690472 - J Clin Invest. 1984 Jan;73(1):116-23
– reference: 16899945 - Clin Hemorheol Microcirc. 2006;35(1-2):291-5
– reference: 2947642 - Blood. 1987 Jan;69(1):124-30
– reference: 9436619 - Free Radic Biol Med. 1998 Jan 1;24(1):102-10
– reference: 3401593 - Blood. 1988 Aug;72(2):539-45
SSID ssj0020997
Score 2.3420951
Snippet 1 EA 3596, Laboratoire ACTES, Département de Physiologie, Université des Antilles et de la Guyane, Campus de Fouillole, Pointe-à-Pitre, Guadeloupe 2 UMR S 763...
Recent evidence suggests that red blood cell aggregation and the ratio of hematocrit to blood viscosity (HVR), an index of the oxygen transport potential of...
Recent evidence suggests that red cell aggregation and the ratio of hematocrit to blood viscosity, an index of the oxygen transport potential of blood, might...
Background Recent evidence suggests that red blood cell aggregation and the ratio of hematocrit to blood viscosity (HVR), an index of the oxygen transport...
SourceID doaj
unpaywall
pubmedcentral
hal
proquest
pubmed
pascalfrancis
crossref
highwire
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1060
SubjectTerms Anemia, Sickle Cell - blood
Anemia, Sickle Cell - genetics
Anemias. Hemoglobinopathies
Biological and medical sciences
Biological Transport
Blood Viscosity
Diseases of red blood cells
Erythrocyte Aggregation
Erythrocyte Deformability
Erythrocytes - metabolism
Fibrinogen - metabolism
Hematocrit
Hematologic and hematopoietic diseases
Hemoglobin C - metabolism
Hemoglobin C Disease - blood
Hemoglobin C Disease - genetics
Hemoglobin, Sickle - metabolism
Hemorheology
Homozygote
Humans
Life Sciences
Medical sciences
Original
Oxygen - metabolism
SummonAdditionalLinks – databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZGJwEvXDYu4TIshHgibRLn5scyMVWITQhRNJ4iO3aaamlSrSlV94_4l5zjXKCABHusax_fvmOfEx9_JuQVDzXXMtV25nmp7StH2jzTrh2hf505QivDrn96Fk6m_vvz4HyPBN1dmFwgVWmr9w1PcDOCI4Xk8ZVQI0BNMPLQD79B9kM8VxqQ_enZx_FXc2LAwR1yzAoMOzVqu-c2V-YY2A69_C6KMmCRu7MlGeZ-2GhyjIvsOYMxZFKsYNSy5rmLv9mjf4ZV3lqXS7HdiKL4Zc86uUu-dL1tQlUuhutaDtOr34ggrz0c98id1oql4ybXfbKnywNyOC5ByGJLX1MTV2o-2B-Qm6ft8f0h-f5JK2pC5SkeGFAxA29_ZrDxpv-hKd5fKWd1TkWpKDQdME7rjoSdLqsaI5yg-iprhYlLTYUs0fwu6LykEuBH82pRXW1n1XpFAYkXhW7rLPViLozoJtnO9aJCXhQoeEzbA6sHZHry7vPxxG7firDTIIxrG6_MRjp1mASbQyuVSjCFpEZrTjsppHM_Vm6ogiDQjisz6fp4BdhLdSxZKkP2kAzKqtSPCWUik0zFgOFA-FJx7kkweqMoyCKeMYdbhHVwSdKWSB3f8ygScKgQZEk3a-0bnwZkFrH7UsuGSOQf-d8iEvu8SANuEgAESQuCxA8Zi3yeRUoL39cuqFmmGYfOKe1FSljkJeB4R8Zk_CHBNDDlYe3l3jeo6UUH82QF81QAir1ks9lwP4mhjaFjkaMd9PcCwZ8FCzNkFqGdOiSwPOF0wmzCBCcRYwG00A8t8qjRjp-952iLs9gi0Y7e7DR3959ynhsGdC9ykXXIIsNew_5rUJ9ct8BTcrs5PsSIz2dkUF-u9XOwQmt51K45PwDzS4qY
  priority: 102
  providerName: Unpaywall
Title Red blood cell aggregation, aggregate strength and oxygen transport potential of blood are abnormal in both homozygous sickle cell anemia and sickle-hemoglobin C disease
URI http://www.haematologica.org/cgi/content/abstract/94/8/1060
https://www.ncbi.nlm.nih.gov/pubmed/19644138
https://www.proquest.com/docview/733574946
https://hal.science/hal-04596392
https://pubmed.ncbi.nlm.nih.gov/PMC2719028
https://haematologica.org/article/download/5315/23304
https://doaj.org/article/4633749f7dea44e19fefe39b14de27da
UnpaywallVersion publishedVersion
Volume 94
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1592-8721
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020997
  issn: 1592-8721
  databaseCode: KQ8
  dateStart: 19940101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1592-8721
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020997
  issn: 1592-8721
  databaseCode: DOA
  dateStart: 19940101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1592-8721
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020997
  issn: 1592-8721
  databaseCode: DIK
  dateStart: 19940101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1592-8721
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020997
  issn: 1592-8721
  databaseCode: RPM
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQkYALghZo-FgshDgRmsRJHB-XimqFaIUQlcopsuPJZkU2WXWzLMs_4l8ydj5oBFI5cIyT2I7nxX5jj58JeSliEKAycPMgyNxQe8oVOfguN_517knQVl3_9CyenYfvL6KLK0d9mZiwVh64bbijMGaMhyLnGmQYgo855cCE8kMNAdeWGuEw1jtTnatl9oPa9QOBzhGOgu2mOYbs4aiQRgy1Lvs4yohxfzQoWe1-HGoKExk5qAaboEm5xnbL2wMv_sZI_wysvL2pVnK3lWV5ZdQ6uUfudnSTTtvPvE9uQLVPDqYVVm25o6-oDQC1M-v75NZpt85-QH5-Ak1tTDs1M_tUztEtn1sjvh4ugJqNJtW8KaisNK2_7xCMtOnV0umqbkwoEhZf511m8hKoVJXhySVdVFQhTmhRL-sfu3m9WVOEzNcSujIrWC6kzbpNdgtY1kbABF88pt3K0gNyfvLu8_HM7Q51cLMoThrX7G3lkHlMITkArTOFnEWBoV3gZZguwkT7sY6iCDxf5Whos1c3yCBRLFMxe0j2qrqCQ0KZzBXTCYItkqHSQgQK2SnnUc5FzjzhENZbNc06xXNz8EaZoudjsJD2WOgO47RYcIg7vLVqFT-uef6tAczwrNHrtgmI4rRDcXodih3yAuE2ymM2_ZCaNOTc2EmK4BuW9LxHY7pGO5UItiDdbrciTBOsY-w5ZDIC6ZAhOp5IBWPmENqjNsV-xJgTrYkGTjljEdYwjB3yqAXx768XhjSzxCF8BO9Rdcd3qkVhpcoD7ht5IIe8GX6Ef2rUx_-jUZ-QO-3anwnXfEr2mssNPEMK2aiJ7S0mdm5vQm6en32cfvkFXwV1QA
linkProvider Directory of Open Access Journals
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZGJwEvXDYu4TIshHgibRLn5scyMVWITQhRNJ4iO3aaamlSrSlV94_4l5zjXKCABHusax_fvmOfEx9_JuQVDzXXMtV25nmp7StH2jzTrh2hf505QivDrn96Fk6m_vvz4HyPBN1dmFwgVWmr9w1PcDOCI4Xk8ZVQI0BNMPLQD79B9kM8VxqQ_enZx_FXc2LAwR1yzAoMOzVqu-c2V-YY2A69_C6KMmCRu7MlGeZ-2GhyjIvsOYMxZFKsYNSy5rmLv9mjf4ZV3lqXS7HdiKL4Zc86uUu-dL1tQlUuhutaDtOr34ggrz0c98id1oql4ybXfbKnywNyOC5ByGJLX1MTV2o-2B-Qm6ft8f0h-f5JK2pC5SkeGFAxA29_ZrDxpv-hKd5fKWd1TkWpKDQdME7rjoSdLqsaI5yg-iprhYlLTYUs0fwu6LykEuBH82pRXW1n1XpFAYkXhW7rLPViLozoJtnO9aJCXhQoeEzbA6sHZHry7vPxxG7firDTIIxrG6_MRjp1mASbQyuVSjCFpEZrTjsppHM_Vm6ogiDQjisz6fp4BdhLdSxZKkP2kAzKqtSPCWUik0zFgOFA-FJx7kkweqMoyCKeMYdbhHVwSdKWSB3f8ygScKgQZEk3a-0bnwZkFrH7UsuGSOQf-d8iEvu8SANuEgAESQuCxA8Zi3yeRUoL39cuqFmmGYfOKe1FSljkJeB4R8Zk_CHBNDDlYe3l3jeo6UUH82QF81QAir1ks9lwP4mhjaFjkaMd9PcCwZ8FCzNkFqGdOiSwPOF0wmzCBCcRYwG00A8t8qjRjp-952iLs9gi0Y7e7DR3959ynhsGdC9ykXXIIsNew_5rUJ9ct8BTcrs5PsSIz2dkUF-u9XOwQmt51K45PwDzS4qY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Red+blood+cell+aggregation%2C+aggregate+strength+and+oxygen+transport+potential+of+blood+are+abnormal+in+both+homozygous+sickle+cell+anemia+and+sickle-hemoglobin+C+disease&rft.jtitle=Haematologica+%28Roma%29&rft.au=Tripette%2C+Julien&rft.au=Alexy%2C+Tamas&rft.au=Hardy-Dessources%2C+Marie-Dominique&rft.au=Mougenel%2C+Daniele&rft.date=2009-08-01&rft.eissn=1592-8721&rft.volume=94&rft.issue=8&rft.spage=1060&rft_id=info:doi/10.3324%2Fhaematol.2008.005371&rft_id=info%3Apmid%2F19644138&rft.externalDocID=19644138
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0390-6078&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0390-6078&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0390-6078&client=summon